High-Dose Isoniazid Among Adult Patients With Different Genetic Variants of INH-Resistant Tuberculosis (TB)

NCT01936831 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
282
Enrollment
NETWORK
Sponsor class

Conditions

Interventions

Sponsor

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

Collaborators